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Abstract 
In this study we provide an empirical evidence on sport inactivity as an important risk factor for 
several chronic diseases, accounting for a significant part of related economic burden of disease. 
Applying cost-of-illness methodology to cost data for a sample of noncommunicable diseases in 
Poland and Germany we present estimates for a fraction of costs (both direct and indirect) 
generated for national health care systems by insufficient sport activity of Polish and German 
populations. Discussing the results we pledge in favor of adequate public incentives and pro-
healthy lifestyle initiatives at both national and EU levels as an effective tool in raising health 
condition. 
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Introduction 
A sedentary lifestyle is a serious societal issue in developed countries. Within a few decades, physical 
inactivity has become one of the leading risks to European citizens’ wellbeing and a growing 
challenge for European societies. Unfortunately, physical inactivity, significantly increases the risk 
of many diseases, including forms of cancer, diabetes, coronary diseases and may also lead to 
obesity. The current situation is already alarming. The World Health Organization (WHO) 
estimates that 25% of European adults, and 80% of European adolescents, are insufficiently active 
(WHO, 2010); Yet, physical inactivity is the fourth leading factor of mortality (WHO, 2009). Thus, 
the health consequences of sedentary lifestyles are significant, and dangerous. Even individuals of 
normal weight who do not reach the recommended levels of physical activity are at significantly 
increased risk of developing cancer, type II diabetes, heart disease and suffering from premature 
death. Eventually, physical inactivity - through 4 major non-communicable diseases (coronary heart 
disease, type 2 diabetes, colorectal and breast cancer) - generates substantial economic costs for  
health systems and is also responsible for productivity loss in European economies. Indeed, 
physical inactivity has become a major public health issue.  
WHO Member States have agreed on a set of nine voluntary global targets to be attained by 2025. 
One of them focuses on a 10 per cent reduction in the prevalence of insufficient physical inactivity 
while the another one concentrates on haltering the rise in diabetes and obesity - conditions for 
which physical inactivity remains an important risk factor. Referring to these goals, our study 
quantitatively evaluates the costs of diseases as a substantial burden for health systems.  
 
Methods and study materials 
In this paper, we attempt to quantify the burden of physical inactivity for the national health system 
in Poland and Germany. As we have mentioned before, etiopathogeneses of several 
noncommunicable diseases (NCDs) point out the physical inactivity. Therefore, our study is a 
prevalence-based top-down cost-of-illness analysis based on investigation of cost burden imposed 
by major NCDs: coronary heart disease (CHD), type 2 diabetes, breast and colon cancers. The 
associated empirical procedure is split into three steps. First, relying on WHO methodology and 
Lancet (2012) study, we identify the Population Attributable Fractions (PAFs) associated with 
physical inactivity for our series of NCDs. As a further step, we calculate direct and indirect costs 
of NCDs. Finally, using the PAFs, we estimate a cost burden of diseases generated by physical 
inactivity. 
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Population Attributable Fraction (PAF) 
PAF is the proportional reduction in population disease that would occur if exposure to a risk 
factor was reduced to an alternative ideal exposure scenario (e.g. physical activity). Many diseases 
are caused by multiple risk factors, and individual risk factors may interact in their impact on overall 
risk of disease. In our case, the PAF is calculated by examining the prevalence of inactivity among 
Polish and German adults and the relative risk of the four diseases for which there is a strong 
evidence of negative impact of sport inactivity. The relative risk measures the association between 
physical inactivity and a particular medical condition and is determined by dividing the rate of the 
disease among inactive people by the rate of disease among active people. Formulae for calculation 
of Population Attributable Fraction (PAF) is presented in Equation 1: 
𝑃𝐴𝐹(%) =
𝑃𝑒(𝑅𝑅𝑢𝑛𝑎𝑑𝑗 − 1)
𝑃𝑒(𝑅𝑅𝑢𝑛𝑎𝑑𝑗 − 1) + 1
∗ 100          (1) 
where Pe is the proportion of inactive people in country’s population, and RRunadj is the relative risk 
of disease, comparing inactive with active people, unadjusted for confounding factors1. Estimation 
of PAF relies on availability of RRs estimates. In order to guarantee a methodological cohesion as 
well as data material that will enable us to undertake an international benchmarking in the future, 
we use the Lancet (2012) estimates for prevalence of physical inactivity, RRs and corresponding 
PAFs2.  
 
Direct and indirect costs of diseases 
As mentioned by Segel (2006), a comprehensive cost-of-illness study should include both direct 
and indirect costs of disorders. Direct costs measure the opportunity cost of resources used for 
treatment of a particular disease, whereas indirect costs reflect the value of resources lost due to a 
particular illness. In this study, evaluation of direct costs includes: the costs of medical care (i.e. 
hospitalizations, physicians visits) and illness-related medication reimbursement calculated from 
                                                          
1  A confounding variable is a factor (e.g. high Body Mass Index, proxy of obesity) that can cause the disease under 
study (e.g.type 2 diabetes) and is also associated with the exposure of interest (e.g. physical inactivity). 
2 Physical inactivity is defined as an activity level insufficient to meet present WHO recommendations (WHO, 2010); 
Estimates of prevalence of physical inactivity are based on cohort studies worldwide and RRs for CHD, type 2 
diabetes, breast and colon cancers result from meta-analysis. For details see Sattelmair et al. (2011), Jeon et al. (2007), 
Wolin et al. (2009),  Lollgen et al. (2009), Monninkhof et al. (2007). 
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the payer perspective3. Non-medical direct costs, such as transportation costs or costs of informal 
care, as well as intangible costs (e.g. costs associated with family separation or failures to meet 
professional goals) have been omitted.  For Poland, the costs of medical care were calculated on 
the basis of National Health Fund (Narodowy Fundusz Zdrowia, NHF) data. In Poland, NHF 
gathers data of costs of services in compliance with WHO’s ICD-10 classification (International 
Statistical Classification of Diseases and Related Health Problems). Consequently, we have 
proceeded with extraction of expenditure data incurred by health care providers in 2010 for our 
series of NCDs. For Germany, the cost of care were calculated upon cost-of-illness accounts 
compiled by the Federal Statistical Office (Statistisches Bundesamt, SB). The latest available series 
consists of 2008 data (Das Informationssystem der Gesundheitsberichterstattung des Bundes).  
The costs of drug reimbursement in Poland are partially evaluated upon information available in 
NHF report4. Unfortunately, with the available data, we could not precisely determine the amount 
of reimbursement matching ICD-10 disease classification. Therefore, we only present the estimates 
for the group of coronary heart diseases and diabetes5. The costs of drug reimbursement in 
Germany are calculated upon the value of pharmaceuticals prescribed at the expense of the 
statutory health insurance and based on German Drug Index6. We use Eisl et al. (2014) study to 
identify drugs matching the ICD-10 classification7. 
Indirect costs evaluated in this study are based on the level of productivity loss due to work absence 
or inability to work and premature mortality due to CHD, type 2 diabetes, breast and colon 
cancers8. In order to calculate these costs for Poland, we used data from Central Statistical Office 
of Poland (GUS) and Social Insurance Institution (ZUS) and applied the human capital method. 
More precisely, the costs of lost productivity due to sickness absence were determined using the 
ZUS data on the number of days taken off due to sickness caused by CHD, type 2 diabetes, colon 
or breast cancers and the average daily gross wage in Poland (EUR 35,35 in 2010, EUR/PLN 
exchange rate as of 31/12/2010). Additionally, the indirect costs are magnified by lost productivity 
due to incapacity to work (handicap) and calculated upon the ZUS data on the number of claimants 
                                                          
3 In Poland, due to marginal share of co-payments in public health system, calculating costs from the payer 
perspective constitutes a good estimate of social cost. 
4 Report available at: 
http://www.nfz.gov.pl/download/gfx/nfz/pl/defaultstronaopisowa/349/14/1/refundacja_2010.pdf (accessed on 
2016.07.15) 
5 In order to calculate the value of drugs reimbursement for Type 2 diabetes, we have subtracted the value of insulin-
based medicines. 
6 The German Drug Index is realized as research project by the AOK Research Institute (WidO). 
7 Pharmaceuticals are classified following the WHO’s Anatomical Therapeutic Chemical (ATC) Classification 
System. 
8 Due to data availability, calculation of indirect costs accounting for premature mortality are only possible for 
Germany. 
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for social security benefits. Available data did not allow us to estimate the value of productivity loss 
due to premature death caused by one of the diseases. 
Indirect costs for Germany are based on the value of years lost due to sickness resulting in work 
incapacity, handicap or premature mortality. As a further step, the number of years lost is multiplied 
by the average annual gross wage in Germany (36 276 € in 2008).  
 
Results 
PAFs inform us about the reduction in a disease incidence once we eliminate the risk factor. In our 
study, the related risk factor is the insufficient physical activity. Estimates for Poland and Germany 
are presented in Table 1: 
Tab. 1: Population Attributable Fraction Estimates 
ICD-10 Disease 
classification 
 
  
Estimated prevalence 
of physical inactivity (95% 
confidence interval), % 
 
 
Median 
value for 
Europe* 
Estimated population 
attributable fractions (PAFs), 
calculated using unadjusted 
relative risks and associated 
with physical inactivity 
Median value for 
Europe* 
 Poland Germany  Poland Germany  
Coronary heart disease 
(I20-I25) 
33,1 (12,9-
84,8) 
33,6 (13,0–87,0) 39,7 8,4 (1,7-
15,3) 
8,5 (1,8–15,6) 9,8 
Type 2 diabetes (E11) 33,9 (12,8-
89,9) 
34,4 (12,9–92,2) 40,7 14,8 (3,0-
27,5) 
15,0 (3,1–27,0) 17,2 
Breast cancer (C50) 33,2 (11,9-
92,5) 
29,9 (10,4–86,2) 37,4 9,7 (2,9-
16,0) 
8,8 (2,4–15,0) 10,8 
Colon cancer (C18) 33,7 (12,2-
92,6) 
34,2 (12,3–94,9) 40,3 9,5 (2,2-
16,1) 
9,6 (2,3–16,2) 11,2 
*Europe: EU-28, Bosnia and Herzegovina, Georgia, Kazakhstan, Norway, Russian Federation, Serbia, Turkey, Ukraine. Source: Lancet (2012) 
 
The PAF of 8,4 (Poland) and 8,5 (Grmany) means that 8,4% (and 8,5%, respectively) of CHDs 
cases would be avoided if the risk factor is causally related to ischemic heart diseases and is 
eliminated. 
Table 2 summarizes direct medical costs: 
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Tab.2: Direct medical costs of outpatient and inpatient care for Polish and German providers of health services 
ICD-10 Disease classification Direct medical costs (in million Euros)* 
 Poland 
 
Germany 
Coronary heart disease (I20-I25) 578,48 
                                                    
6 202,0 
Type 2 diabetes (E11) 48,46 
 
5 073,6** 
Breast cancer (C50) 123,17 
                                                   
1 970,0 
Colon cancer (C18) 46,50 
                                                   
 1 050,0 
Total :                                          796,61  
                                                
 14 295,6 
% of total statutory insurance expenditure in 
2010: 9% 
 
5,6% 
*EUR/PLN exchange rate as of 31/12/2010; authors’ calculation 
**Type 2 diabetes costs are estimated as a fraction of total diabetes costs (E10-E11). It is estimated that type 2 diabetes generate 80% percent of 
total expense for diabetes. 
 
The highest direct medical costs in both countries are generated by CHDs, followed by diabetes 
(in Germany) and breast cancer (in Poland). 
The amount of reimbursement is based on the part of total Polish NHF drug reimbursement 
expense and reported in Table 3 below: 
Tab.3: Reimbursement of medicines 
ICD-10 Disease classification                Drug reimbursement (in million Euros)* 
 
Poland 
 
 
Germany 
Coronary heart disease (I20-I25)                                                                   267,38                                       97,2 
Type 2 diabetes                                                                    113,33                                       31,7 
Breast cancer (C50) N/A 5,1 
Colon cancer (C18) N/A 33,9 
 
% of total drugs reimbursement expense 
 
17,67% 
 
27,6% 
*EUR/PLN exchange rate as of 31/12/2010; authors’ calculation 
 
Total indirect costs generated by one of sample diseases are presented in Table 4a (Poland) and 4b 
(Germany): 
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Tab.4a: Estimates of indirect costs for Poland 
ICD-10 Disease 
classification 
Number of absence days Numer of people 
receiving an imparied-
life annuity adjusted 
by an employment-
to-population ratio 
Productivity loss 
due to sickness 
absence (in million 
Euros) 
Productivity loss 
due to incapacity 
for work (in 
million Euros) 
Indirect costs 
(in million 
Euros) 
Coronary heart disease 
(I20-I25) 
3 062 425 74 615                    108,26                2,64   110,89  
Type 2 diabetes (E11) 595 342 5 997                21,05                 0,21      21,26  
Breast cancer (C50) 714 113 8 932                25,24                 0,32      25,56  
Colon cancer (C18) 205 625 2 256                  7,27                0,08        7,35  
Total: 4 577 505 91 801              161,81                 3,25    165,06  
*EUR/PLN exchange rate as of 31/12/2010; authors’ calculation 
 
 
Tab.4b: Estimates of indirect costs for Germany 
 
ICD-10 Disease 
classification 
Total number of lost 
workforce years (in 
thousand years) 
 
 
 
Of which: 
 
 
 
 
 
Lost workforce years 
due to premature 
mortality 
 
 
 
 
 
Lost workforce 
years due to 
sickness absence  
 
 
 
 
 
Lost workforce 
years due to 
incapacity for 
work 
Indirect costs 
(in million 
Euros) 
 
 
 
Coronary heart disease 
(I20-I25) 
124 80                  22   22                4 498,22   
Type 2 diabetes (E11) 36 13          9                14                 1 305,94      
Breast cancer (C50) 60 23         17                                      20      2 176,56      
Colon cancer (C18) 23 N/A         N/A                                       
N/A               
834,35        
Total: 243 
 
                              8 815,07     
 
Multiplying PAFs by the amount of total costs of diseases (direct and indirect) provides us with 
the estimates of possible cost savings due to raise in physical activity in population. The annual 
estimates of cost savings are presented in Table 5a (Poland) and 5b (Germany) below: 
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Tab. 5a: Cost burden of diseases attributable to physical inactivity in Poland 
ICD-10 Disease 
classification 
Direct costs (in 
million Euros) 
Indirect costs 
(in million Euros) 
Total costs (in 
million Euros) 
PAFs Estimated reduction in total costs due to 
elimination of insufficient physical 
inactivity in population (in million 
Euros) 
Coronary heart 
disease (I20-I25) 
845,86* 110,89 956,75 8,5 80,37 
Type 2 diabetes 
(E11) 
        161,79* 21,26 183,05 15,0 27,09 
Breast cancer (C50)              123,17 25,56 148,73 8,8 14,43 
Colon cancer (C18)            46,50 7,35 53,85 9,6 5,11 
Total:         1 177,32 165,06 1 342,38 
 
127,00 
*includes drugs reimbursement; EUR/PLN exchange rate as of 31/12/2010 
 
Tab. 5b: Cost burden of diseases attributable to physical inactivity in Germany 
 
ICD-10 Disease 
classification 
Direct costs (in 
million Euros) 
Indirect costs 
(in million Euros) 
Total costs (in 
million Euros) 
PAFs Estimated reduction in total costs due to 
elimination of insufficient physical 
inactivity in population (in million 
Euros) 
Coronary heart 
disease (I20-I25) 
6 299,2 4 498,22   10 797,42 8,4 906,98 
Type 2 diabetes 
(E11) 
5 105,3         1 305,94      6 411,24 14,8 948,86 
Breast cancer (C50)             1 975,1 2 176,56      4 151,66 9,7 402,71 
Colon cancer (C18)        1 083,9     834,35        1 918,25 9,5 182,23 
Total:         14 463,5 8 815,07 23 278,57 
 
2 440,78 
 
 
In Poland, direct costs related to CHD, type 2 diabetes, breast and colon cancers were of                      
1 77,32 million Euros and accounted for 87,7% of total costs. 71% of total costs are generated by 
CHD. The PAF ranges from 8,5 (CHD) to 15 (type 2 diabetes). Estimated cost burden of diseases 
attributable to physical inactivity amounted 127 million Euros, thus accounting for 9,5% of total 
cost burden imposed by CHD, type 2 diabetes, breast and colon cancers.  
In Germany, 73% of total costs are generated by CHD and type 2 diabetes. Indirect costs associated 
with breast cancer exceed the direct costs. The indirect costs are mostly generated by premature 
mortality due to CHD. The PAF ranges from CHD (8,4) to 14,8 (type 2 diabetes). Estimated total 
burden of diseases attributable to physical inactivity reaches the level of nearly 2,5 billion Euros, 
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accounting for more than 10% of total cost burden imposed by CHD, type 2 diabetes, breast and 
colon cancers. 
 
Discussion 
Poland 
In order to assess the estimated burden of diseases attributable to physical inactivity, we relate it to 
the public expenditure for physical culture and sport in 2010. Analysis of the ‘2010 State budget’ 
reveals that total expenditure for physical culture and sport amounted to EUR 448,08 million (only 
0,60% of total budget spending). Thus, the costs of medical conditions associated with insufficient 
physical inactivity accounts for slightly more than 28% of the amount spend on raising participation 
of Poles in sport and its promotion. It is worth mentioning that since 2007, increasing physical 
activity of population has been announced in national strategies for sport and public health9. To 
this day, there is no priority Health Plan focusing on sport participation for Polish citizens. 
Analyzing data on sport practice in clubs, in 2012 there were 490 thousand actively practicing 
members of sport clubs, compared to 486 thousand in 2010 (almost a steady rate).                  
However, 60% of those members were persons aged up to 18.  
At the same, ‘Participation of Poles in sports and physical recreation’ study10 delivers interesting 
insights about sport habits of Polish citizens. During the study period (10/2011-09/2012) 45,9% 
of Poles participated in any kind of sport activity (48,8% men and 43,3% women). Over one fifth 
of respondents (20,3%) practiced sport regularly and more than a quarter (25,6%) sporadically. 
Moreover, the study revealed the inverse to the age subjective evaluation of physical condition. 
Very good or good physical performance status has most often been declared by young people (5-
9 years – 95,1%, 10-14 years – 94,4%, and 91,7% aged 15-19); people aged from 20 to 29 years 
more frequently reported limited shortcomings of physical fitness (13,2%). With age, self-evaluated 
physical condition significantly deteriorates (very good or good condition has been reported only 
by 40,1% of people aged 50-59 years, and 17,7% among people aged 60 and older. More than 38% 
of seniors (aged 60 or older) has estimated their physical condition as bad or very bad. This pyramid 
of physical performance corresponds to the prevalence of CHD and colorectal cancer in developed 
countries11. Therefore, public authorities should manifest more efforts in increasing health 
                                                          
9 ‘Strtegia rozwoju w Polsce do roku 2015’ and ‘Narodowy plan zdrowia 2007-2015’ 
10KiGGs German Health Interview and Examination Survey for Children and Adolescents, 1st Wave, 2009-2012, 
conducted by the Robert Koch Institute. 
11 See Ferreira-Gonzalez (2014) 
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condition of population by raising sport participation of 50+ citizens. An inclusive, senior-tailored 
plans based on adequate incentives (e.g. creating or subsidizing senior sport clubs) would permit 
not only elevate the health status of elderly people, but also decrease the incidence of costly 
diseases. Accidentally, raising sport participation among seniors will help fighting against social 
exclusion.  
Germany 
In Germany, the average annual revenue allocated to sport from the central government’s budget 
in 2008 was EUR 229,91 million. Germany has a decentralized administrative organization,  and 
the Länders are autonomous concerning sport. The average annual revenue allocated to sport by 
the local authorities was EUR 184, 5 million in 2008. 12 
In 2012, there were 23, 72 million sport clubs members, and the participation has slightly decreased 
since 2010. This decrease of sport participation in Germany can be partly explained by the drop in 
participation of youths, since the population of young people displays a decreasing trend.  
According to the 2009 Eurobarometer Survey, in Germany 31% of the persons asked declared not 
practicing sport at all. Young people are physically more active than remaining age groups, but do 
not practice enough exercise. 
The young people and children health survey 2009-2012 (kiGGS) 13 collected data on the 
assessment of parents regarding the general health of their children, as well as on the self-
assessment of 11 to 17 year olds. 93.6% of the parents assess the general health of their children 
as “Very good” or “Good”. The proportion of children with fair or poor general health is 6.4%. 
No significant differences between girls and boys are apparent from the information given by 
parents. Moreover, approximately 5% of girls and boys of pre-school or primary school age have 
fair or poor general health. At the beginning of adolescence, this figure rises in both girls and boys 
to approximately 9% in the age group from 14 to 17. 
In Germany, 51% of the adult population suffers from obesity, among which 15 % are people  
aged 18 years or younger. This problem decreases with income and educational levels. During the 
last 10 years, the obesity rate among young men increased by 8% and by 7% among  girls. 
                                                          
12 ‘Eurostrategies, CDES, Amnyos, CDES, DSHS Köln (2011) Study on the funding of grassroots sports in the EU 
With a focus on the internal market aspects concerning legislative frameworks and systems of financing. 
13 Study conducted by the Central Statistical Office in October 2012 on the sample of households participating in the 
Household Budget Survey (HBS). 
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In 2008, the national Program “In form” was initiated by two ministries (for health and agriculture 
and for nutrition, respectively Bundesministerium für Ernährung und Landwirtschaft und  
Bundesministerium für Gesundheit) to improve on the long run the physical activity and the 
nutrition of the German population. For the 3 first years, a budget amount of EURO 15 million 
per year was distributed. By 2020, two objectives must be met: nutrition and physical activity have 
to be improved and the rate of diseases caused by the lack of physical activity or a bad nutrition 
has to be reduced. 
 
Study limitations 
Our study has two main limitations. First, the presented cost perspective is static. It provides the 
costs estimate only for 2010 (Poland) and 2008 (Germany). Due to data unavailability, we were 
unable to undertake a dynamic perspective. However, combining morbidity trends and NHF 
expenses and investigating existing studies, we can be certain of increase in the cost burden related 
to CHD, type 2 diabetes, breast and colon cancers. Second, complete cost-of-illness studies should 
include comorbidities. We have decided not to expand for complications as there are doubts about 
the direction of causal relationship (for instance, it is not clear whether obesity is a cause or a 
consequence of diabetes). 
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